Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoval of the government funding status notice from the page footer; study details and all other content remain unchanged.SummaryDifference0.3%

- Check35 days agoChange Detected- The Study Details page now shows the Results First Posted date and results data, including primary/secondary outcomes and adverse events, with updated enrollment and completion dates. - Updated sections reflect the trial's progress and outcomes; additional QoL and biomarker data are also listed.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor changes: add government funding/status notice and version v3.2.0; remove a specific resource and older version v3.1.0.SummaryDifference0.9%

- Check71 days agoChange DetectedTerminology refined from “Head and neck squamous cell carcinoma” to “Squamous cell carcinoma of the head and neck” and version updated from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check85 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; 'Back to Top' removed.SummaryDifference0.0%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.